Table 3. Summary of Primary End Points of Clinical Trials of Dual Anti-Platelet Therapy After Drug Eluting Stents Implantation.

Primary end Points	Shorter, ≤ 6 mo, (n = 4993)	Longer, ≥ 12 mo, (n = 4986)	OR	P Value
All causes of mortality	125	122	1.03 (0.80, 1.32)	0.85
Cardiac death	63	69	0.91 (0.64, 1.29)	0.60
Cerebrovascular	26	31	0.84 (0.50, 1.42)	0.51
MI	96	82	1.17 (0.87, 1.58)	0.29
Stent thrombosis	34	25	1.36 (0.81, 2.29)	0.24
TIMI major bleeding	20	40	0.50 (0.29, 0.85)	0.01